Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene PBRM1
Variant Y608fs
Impact List frameshift
Protein Effect loss of function - predicted
Gene Variant Descriptions PBRM1 Y608fs results in a change in the amino acid sequence of the Pbrm1 protein beginning at aa 608 of 1689, likely resulting in premature truncation of the functional protein (UniProt.org). Y608fs has not been characterized, however, due to the effects of other truncation mutations downstream of Y608fs (PMID: 28082722), is predicted to lead to a loss of Pbrm1 protein function.
Associated Drug Resistance
Category Variants Paths

PBRM1 mutant PBRM1 inact mut PBRM1 Y608fs

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_018313.5
gDNA chr3:g.(52615453_52615454)
cDNA c.(1822_1821)
Protein p.Y608fs
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_001405557.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394868.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006750.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400490.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394867.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405612.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405639.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405626.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400484.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405623.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405558.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006758 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_181042.4 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405565.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394873.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405590.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394874.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405555.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405603.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405605.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405583.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405633.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405593.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_018313 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405556.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_018313.5 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405635.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405640.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405563.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405577.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405588.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405575.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400475.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405634.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405609.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405611.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405585.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006750 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405610.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405624.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405632.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405561.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400504.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405629.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_018313.4 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405631.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405628.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394871.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405570.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_181042.5 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400474.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006748.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394876.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405576.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400501.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001350075.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405578.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006749 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400500.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006765 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006757 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405592.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405630.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405627.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006748 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405589.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394869.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006758.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405581.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_047448462.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400470.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400496.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405643.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400473.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001350075.2 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
XM_017006749.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405584.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405579.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405559.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405641.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400481.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394877.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405567.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001400479.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394875.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001394872.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38
NM_001405594.1 chr3:g.(52615453_52615454) c.(1822_1821) p.Y608fs RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
PBRM1 Y608fs clear cell renal cell carcinoma no benefit Nivolumab Case Reports/Case Series Actionable In a clinical study, Opdivo (nivolumab) treatment resulted in progressive disease in a patient with renal clear cell carcinoma harboring PBRM1 Y608fs (PMID: 29301960). 29301960